TickerStat.com

KYNTRA BIO, INC. (KYNB)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

13 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013
Revenue$6.4M$29.6M$46.8M$140.7M$235.3M$176.3M$256.6M$213.0M$131.0M$183.2M$180.8M$137.6M$102.2M
Research & development$23.5M$95.7M$266.5M$296.8M$387.0M$252.9M$209.3M$235.8M$196.5M$187.2M$214.1M$150.8M$85.7M
Operating expenses—————$368.2M$345.9M$299.7M$248.3M$233.2M$258.5M$187.7M$110.1M
Operating income−$45.9M−$150.4M−$322.7M−$301.0M−$288.5M−$191.9M−$89.3M−$86.7M−$117.3M−$50.0M−$77.6M−$50.1M−$7.9M
Net income$183.5M−$47.6M−$284.2M−$293.7M−$290.0M−$189.3M−$77.0M−$86.4M−$120.9M−$58.1M−$85.8M−$59.5M−$14.9M
Basic EPSper diluted share$45.37-$11.89-$2.92-$3.14-$3.14-$2.11-$0.89-$1.03-$1.66-$0.93-$1.42-$3.17-$1.13
Diluted EPSper diluted share$45.37-$11.89-$2.92-$3.14-$3.14-$2.11-$0.89-$1.03-$1.66-$0.93-$1.42-$3.17-$1.13
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys8$348.2K disclosed value
Sells (SEC code S)0$0.00 disclosed value
8 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 14, 2026Form 4/AWettig ThaneCEOBuyCommon Stock2.8K$7.09$19.9K27.2K
May 14, 2026Form 4Wettig ThaneCEOBuyCommon Stock2.8K$7.09$19.9K27.2K
Nov 17, 2025Form 4Wettig ThaneCEOBuyCommon Stock2.7K$9.10$24.6K24.9K
Nov 13, 2025Form 4Wettig ThaneCEOBuyCommon Stock1.0K$9.18$9.2K22.2K
Jun 30, 2025Form 4Schoeneck James ADirectorBuyCommon Stock · indirect23.6K$5.07$119.5K39.7K
Review ownership filings at SEC.gov ↗